Medtronic receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition
Go back to Medtronic receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition| Medtronic Inc. (NYSE: MDT) | Delayed: 80.36 +1.09 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.27 | 52 Week High | $89.27 | |||
| Open | $79.75 | 52 Week Low | $71.03 | |||
| Day High | $80.66 | P/E | 22.83 | |||
| Day Low | $79.58 | EPS | $3.52 | |||
| Volume | 2,265,753 | |||||
